Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.29%)
As of: Sep 4, 2026 · 1:40 PM EDT

Compugen (CGEN) Cost of Revenue (2010 - 2026)

Compugen (CGEN) posted quarterly Cost of Revenue of $1.8 million for Q1 2026, down 24.0% year-over-year from $2.4 million in Q1 2025, and down 48.42% on a QoQ basis from $3.5 million in Q4 2025.

Analysis

Compugen (CGEN) Cost of Revenue (2010 - 2026) Analysis & Trends

Compugen has reported Cost of Revenue for 14 years, with the latest figure at $1.8 million in Q1 2026.

  • Cost of Revenue for Q1 2026 came in at $1.8 million, down 24.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 million (up 5.43% YoY), and the FY2025 annual result was $9.3 million, up 16.66% from the prior year.
  • Cost of Revenue fell to $1.8 million in Q1 2026, from $3.5 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $3.6 million in Q3 2024 and troughed at $675000.0 in Q4 2024.
  • A 5-year average of $2.0 million and a median of $1.8 million in 2026 frame the typical range for Cost of Revenue.
  • The widest annual swing landed in 2024, when Cost of Revenue slumped 66.32%; it then soared 423.85% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $975000.0 in 2022, then jumped by 105.54% to $2.0 million in 2023, then slumped by 66.32% to $675000.0 in 2024, then soared by 423.85% to $3.5 million in 2025, then slumped by 48.42% to $1.8 million in 2026.
  • Per Business Quant data, the three most recent Cost of Revenue figures were $1.8 million in Q1 2026, $3.5 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 145.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 93.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 174.53 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 298.26 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 67.21 Mn
10 Compugen 241.97 Mn 156.35 Mn -92,000.00 2.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.69 Mn
Mar 31, 2026 1.82 Mn
Dec 31, 2025 3.54 Mn
Sep 30, 2025 1.65 Mn
Jun 30, 2025 1.67 Mn
Mar 31, 2025 2.40 Mn
Dec 31, 2024 675,000.00
Sep 30, 2024 3.60 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 2.10 Mn
Sep 30, 2021 680,000.00
Sep 30, 2018 684,000.00
Mar 31, 2018 350,000.00
Dec 31, 2016 35,000.00
Sep 30, 2016 21,000.00
Jun 30, 2016 86,000.00
Mar 31, 2016 81,000.00
Dec 31, 2015 1.04 Mn
Sep 30, 2015 201,000.00
Jun 30, 2015 148,000.00